Impact of ferritin serum concentration on survival in children with acute leukemia: a long-term follow-up
Abstract
Introduction: Nowadays, a significant number of children with acute leukemia can be cured. Iron overload, related to blood transfusions and its long-term complications, remains a problem. Elevated ferritin concentration is often observed in this group. The aim of this study was to evaluate the prognostic value of serum ferritin on long-term outcomes in children treated for acute leukemia. Material: We studied 71 patients treated for acute lymphoblastic (ALL) or myeloblastic (AML) leukemia between 2005 and 2011. Serum ferritin concentration, serum transaminases activity, lactic dehydrogenase and C-reactive protein levels (CRP) were analysed. Serum ferritin >1,000 µg/L was considered to be a marker of iron overload. Results: Thirty-seven patients (52.1%) had iron overload. Ferritin serum concentration correlated with alanine aminotranferase activity (p =0.001) and CRP concentration (p =0.012). A total of 19 (26.76%) patients died during follow-up. Ferritin level was higher in patients with AML vs. ALL. There was a significant difference in long-term outcomes with respect to high ferritin concentrations, both in patients undergoing haematopoietic cell transplantation (HCT) and in the non-HCT group. Conclusions: In both groups, patients with higher ferritin concentrations had worse overall and event-free survivals and a higher relapse incidence. Ferritin concentration >1,000 µg/L was the strongest determinant of long-term treatment outcome. Ferritin serum concentration >1,000 µg/L is an adverse prognostic marker of survival in children with acute leukemia treated with chemotherapy with or without HCT.
Keywords: ferritinironleukemiachildrenhaematopoietic cell transplantation
References
- Pui CH, Yang J, Bhakta N, et al. Global efforts toward the cure of childhood acute lymphoblastic leukaemia. Lancet Child Adolesc Health. 2018; 2(6): 440–454.
- Demidowicz E, Pogorzala M, Łęcka M, et al. Outcome of pediatric acute lymphoblastic leukemia: sixty years of progress. Anticancer Res. 2019; 39(9): 5203–5207.
- Balwierz W, Pawinska-Wasikowska K, Klekawka T, et al. Development of treatment and clinical results in childhood acute myeloid leukemia in Poland. Memo. 2012; 6(1): 54–62.
- Meyer SC, O’Meara A, Buser A, et al. Prognostic impact of posttransplantation iron overload after allogeneic stem cell transplantation. Biol Blood Marrow Transplant. 2013; 19(3): 440–444.
- Bernaudin F, Verlhac S, Latour RP, et al. Association of matched sibling donor hematopoietic stem cell transplantation with transcranial Doppler velocities in children with sickle cell anemia. JAMA. 2019; 321(3): 266–276.
- Halyabar O, Chang M, Schoettler M, et al. Calm in the midst of cytokine storm: a collaborative approach to the diagnosis and treatment of hemophagocytic lymphohistiocytosis and macrophage activation syndrome. Pediatr Rheumatol Online J. 2019; 17(1): 7.
- Uppuluri R, Swaminathan VV, Ramanan KM, et al. Haploidentical stem cell transplantation with post-transplant cyclophosphamide in fanconi anemia: improving outcomes with improved supportive care in India. Biol Blood Marrow Transplant. 2020; 26(12): 2292–2298.
- Morgenstern DA, Pötschger U, Moreno L, et al. Risk stratification of high-risk metastatic neuroblastoma: a report from the HR-NBL-1/SIOPEN study. Pediatr Blood Cancer. 2018; 65(11): e27363.
- Majhail NS, Lazarus HM, Burns LJ. Iron overload in hematopoietic cell transplantation. Bone Marrow Transplant. 2008; 41(12): 997–1003.
- Bazuave GN, Buser A, Gerull S, et al. Prognostic impact of iron parameters in patients undergoing allo-SCT. Bone Marrow Transplant. 2011; 47(1): 60–64.
- Bennett TD, Hayward KN, Farris RWD, et al. Very high serum ferritin levels are associated with increased mortality and critical care in pediatric patients. Pediatr Crit Care Med. 2011; 12(6): e233–e236.
- Kikuchi S, Kobune M, Iyama S, et al. Prognostic significance of serum ferritin level at diagnosis in myelodysplastic syndrome. Int J Hematol. 2012; 95(5): 527–534.
- Landier W, Armenian SH, Lee J, et al. Yield of screening for long-term complications using the children's oncology group long-term follow-up guidelines. J Clin Oncol. 2012; 30(35): 4401–4408.
- Michalak S. Perspectives for the therapy of anemia of chronic diseases. Acta Haematol Pol. 2020; 51(3): 125–132.
- Styczynski J. Infectious complications in children and adults with hematological malignancies. Acta Haematol Pol. 2019; 50(3): 167–173.
- Demidowicz E, Bartoszewicz N, Czyżewski K, et al. Acute non-hematological toxicity of intensive chemotherapy of acute lymphoblastic leukemia in children. Acta Haematol Pol. 2020; 51(3): 164–171.
- Styczyński J. ABC of viral infections in hematology: focus on herpesviruses. Acta Haematol Pol. 2019; 50(3): 159–166.
- Bartoszewicz N, Czyżewski K, Dębski R, et al. Efficacy of keratinocyte growth factor in prevention of oral mucositis in children undergoing allogeneic hematopoietic cell transplantation. Acta Haematol Pol. 2020; 51(3): 172–178.
- Styczyński J. Prophylaxis vs preemptive therapy in prevention of CMV infection: new insight on prophylactic strategy after allogeneic hematopoietic cell transplantation. Acta Haematol Pol. 2020; 51(1): 17–23.
- Brierley CK, Iniesta RR, Storrar N, et al. Hyperferritinemia in pediatric acute lymphoblastic leukemia. J Pediatr Hematol Oncol. 2017; 39(3): 238.
